[Interstitial lung disease in patients with primary biliary cirrhosis]

Pneumonol Alergol Pol. 2012;80(5):471-81.
[Article in Polish]

Abstract

Primary biliary cirrhosis (PBC) is a chronic autoimmune disorder of unknown etiology. The disease affects middle-aged women and is characterized by the destruction of the intralobular bile ducts that causes consequent cholestasis. AMA is a hallmark of PBC, composed mostly of IgG and IgM class. The M2 antibody is the most specific one, with sensitivity range of 54-98% depending on type of test used. PBC is often accompanied by other autoimmune diseases, such as Sjögrens syndrome, thyroiditis, rheumatoid arthritis, dermatomyositis, polymyositis. Interstitial lung disease (ILD) has been reported in patients with primary biliary cirrhosis but its frequency and nature are poorly understood. We report pulmonary involvement in the course of PBC in 4 middle-aged women. Histopatological examination of lung specimens was available in three patients: two presented with sarcoid - like granulomas, one with lymphocytic interstitial pneumonia (LIP). In one patient the diagnosis of pulmonary fibrosis was based on clinical and radiological features. Because of abnormal pulmonary function tests (PFT) results all the patients were treated with prednisone, one, additionally with azathioprine. The treatment was successful in all of the patients.

MeSH terms

  • Cholagogues and Choleretics / administration & dosage*
  • Female
  • Humans
  • Liver Cirrhosis, Biliary / complications*
  • Liver Cirrhosis, Biliary / diagnostic imaging*
  • Liver Cirrhosis, Biliary / drug therapy
  • Lung Diseases, Interstitial / complications*
  • Lung Diseases, Interstitial / diagnostic imaging*
  • Middle Aged
  • Poland
  • Respiratory Function Tests
  • Tomography, X-Ray Computed
  • Ursodeoxycholic Acid / administration & dosage*

Substances

  • Cholagogues and Choleretics
  • Ursodeoxycholic Acid